StoneX Group’s Drugs Made In America Acquisition II Corp Right DMIIR Stock Holding History

StoneX Group’s Portfolio DMIIR Stock Details DMIIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.96K	Buy	+100,000	New	+$8.55K	﹤0.01%	1384

Other funds holding DMIIR

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

HIM

HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return

StoneX Group's DMIIR Position: Q2 2026 in Review

StoneX Group opened a new position in Drugs Made In America Acquisition II Corp Right (DMIIR) in Q2 2026: 100,000 shares worth $7.96K. The stake represents ﹤0.01% of the portfolio and ranks #1384 among its holdings.

61 funds tracked by Wall St. Rank hold DMIIR as of Q2 2026.

StoneX Group held 100,000 shares of Drugs Made In America Acquisition II Corp Right worth $7.96K as of Q2 2026.
Drugs Made In America Acquisition II Corp Right was a new StoneX Group position in Q2 2026.
Drugs Made In America Acquisition II Corp Right made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1384 holding.
61 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Right as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.